Rights and permissions
About this article
Cite this article
Glipizide: Pfizer’s oral hypoglycaemic, now approved in the US. Inpharma Wkly. 443, 19–20 (1984). https://doi.org/10.1007/BF03315685
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03315685